Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Albelda

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Nature|September 13, 2019
Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2011
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratioNuala J Meyer, Mingyao Li, Rui Feng, et al.
Science Immunology|April 19, 2017
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patientsThomas Condamine, George A Dominguez, Je-In Youn, et al.
Nature Biotechnology|October 17, 2025
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumorsHaijiao Liu, Estela Noguera-Ortega, Xuanqi Dong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancersJulie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.
Cell|December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023
Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cellsAndrew R Haas, Ryan J Golden, Leslie A Litzky, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Nature|September 13, 2019
Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2011
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratioNuala J Meyer, Mingyao Li, Rui Feng, et al.
Science Immunology|April 19, 2017
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patientsThomas Condamine, George A Dominguez, Je-In Youn, et al.
Nature Biotechnology|October 17, 2025
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumorsHaijiao Liu, Estela Noguera-Ortega, Xuanqi Dong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancersJulie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.
Cell|December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023
Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cellsAndrew R Haas, Ryan J Golden, Leslie A Litzky, et al.
Pageof 20